Nation

Indian vaccine maker Serum Institute of India will manufacture a new Covid-19 vaccine for a crucial clinical trial being carried out by the researchers at Oxford University.

Indian firm makes Covid-19 vaccine for Oxford trials; DBT also funds three home-grown vaccines against the pandemic

New Delhi, April 24: Indian vaccine maker Serum Institute of India will manufacture a new Covid-19 vaccine for a crucial clinical trial being carried out by the researchers at Oxford University.

The vaccine is a weakened version of a common cold virus (adenovirus) from chimpanzees that has been genetically tweaked in such a way that it is impossible to grow in humans. To this virus, the scientists have further added genes to help the body identify a Covid-19 infection and put up a defence against the rampaging virus.

“SII will be manufacturing the vaccine in anticipation of clinical trials succeeding by September – October in the UK. The vaccine will not be made available to the public in two-three weeks as suggested in some media reports,” the company said in a statement.

The Oxford product (ChAdOx1 n-Cov-19) is one of the forerunners of the Covid-19 shots being developed around the world. More than 1,100 participants are to be recruited in study sites in Oxford, Southampton, London and Bristol to evaluate the vaccine that was found safe for use in humans.

The company said it decided to produce the vaccine at its own risk to have a jump start on the manufacturing so that enough doses become available, if the trials work.

With funding support from the Department of Biotechnology, the SII would also initiate a phase-3 clinical trial of recombinant BCG vaccine among high-risk Covid-19 patients.

The DBT approval came earlier this week following scientific observations that nations that offer BCG vaccine to the newborns have lower Covid-19 caseloads and deaths.

“It is an astute observation that in countries with universal infant BCG, there is less transmission and death than in countries without universal BCG. This question is being investigated in Germany and Australia. We shall wait and see their results,” commented T Jacob John, an eminent virologist and retired professor of clinical virology in Christian Medical College Vellore.

Under the National Biopharma Mission, the DBT has also funded Cadila Healthcare Ltd for a DNA vaccine candidate and Bharat Biotech for its inactivated rabies vector platform-based vaccine candidate.

The three vaccine projects are among the 16 programmes that DBT approved for funding to develop (or repurpose) vaccines, diagnostics and drugs to battle the Covid-19 pandemic.

7 Comments

7 Comments

  1. bang hieu alu

    12/05/2020 at 06:39

    Công ty Quảng Cáo Đại Phát cung cấp dịch vụ thiết kế, in ấn và thi công biển bảng quảng
    cáo, biển đèn led, chữ nổi, in ấn hiflex uy tín,
    chất lượng cùng giá thành cạnh tranh nhất trên thị trường
    tại khu vực TP. Hồ Chí Minh

    Làm bảng hiệu quảng cáo tphcm – Một bảng hiệu đẹp với thiết kế thu hút sẽ là lợi thế lớn của
    bạn trong việc quảng bá thương hiệu, và sản phẩm dịch
    vụ.

    Thiết kế, in ấn, thi công bảng biển hiệu quảng cáo đèn LED, chữ nổi Inox, đèn LED
    ma trận, mặt dựng alu, bảng hiệu,
    hộp đèn, tủ kệ nhôm kính giá rẻ.
    – lam bang hieu
    – bang hieu quang cao
    – bang hieu alu

    Quang Cao Dai Phat
    Hotline: 0935 79 00 28
    Email: [email protected]

  2. Remigiusz

    15/05/2020 at 06:47

    Wow, that’s what I was seeking for, what a material!
    existing here at this website, thanks admin of this site.

  3. 우리카지노

    23/05/2020 at 23:22

    Oh my goodness! Impressive article dude! Many thanks, However I am going through problems with your RSS.
    I don’t understand why I am unable to subscribe to it. Is there anybody
    getting the same RSS issues? Anyone who knows the solution can you kindly respond?
    Thanks!! https://Www.woori777.com

  4. view more

    24/05/2020 at 08:55

    I loved as much as you’ll receive carried out right here. The sketch is tasteful, your authored material
    stylish. nonetheless, you command get bought an impatience over that you wish be delivering the following.
    unwell unquestionably come more formerly again as exactly the same nearly very often inside case you shield this hike.

  5. Marian

    06/06/2020 at 11:47

    I always emailed this webpage post page to all my associates, because if like to read it afterward my friends will too.

  6. Great site you’ve got here.. It’s hard to find good quality writing
    like yours these days. I really appreciate people like you!
    Take care!! https://anunturi-parbrize.ro/index.php?page=1345

  7. Hiflex printing company

    01/07/2020 at 15:37

    Hello, its fastidious post about media print, we
    all be familiar with media is a enormous source of
    information.

Leave a Reply

Your email address will not be published.

19 − sixteen =

News is information about current events. News is provided through many different media: word of mouth, printing, postal systems, broadcasting, electronic communication, and also on the testimony of observers and witnesses to events. It is also used as a platform to manufacture opinion for the population.

Contact Info

Address:
D 601  Riddhi Sidhi CHSL
Unnant Nagar Road 2
Kamaraj Nagar, Goreagaon West
Mumbai 400062 .

Email Id: [email protected]

Middle East

IND SAMACHAR
Digital Media W.L.L
Flat: 11, 1st floor, Bldg: A – 0782
Road: 0123, Block: 701, Tubli
Kingdom of Bahrain

Office Address

251 B-Wing,First Floor,
Orchard Corporate Park, Royal Palms,
Arey Road, Goreagon East,
Mumbai – 400065.

Download Our Mobile App

IndSamachar Android App IndSamachar IOS App
To Top
WhatsApp WhatsApp us